Liver Fluke Induces Cholangiocarcinoma by Sripa, Banchob et al.
PLoS Medicine  |  www.plosmedicine.org 1148
Neglected Diseases
July 2007  |  Volume 4  |  Issue 7  |  e201
Opisthorchiasis and Clonorchiasis: Major Regional 
Public Health Problems
Liver ﬂ  uke infection caused by Opisthorchis viverrini, O. felineus, 
and Clonorchis sinensis is a major public health problem in East 
Asia and Eastern Europe. Currently, more than 600 million 
people are at risk of infection with these trematodes [1]. O. 
viverrini is endemic in Southeast Asian countries, including 
Thailand, Lao People’s Democratic Republic, Vietnam, 
and Cambodia [2], and C. sinensis infection is common in 
rural areas of Korea and China. Opisthorchiasis has been 
extensively studied in Thailand, where an estimated 6 million 
people are infected with the liver ﬂ  uke (calculated from 
overall 9.4% prevalence within the population in 2001) [3]. 
Infection with these food-borne parasites is prevalent in 
areas where uncooked cyprinoid ﬁ  sh are a staple of the diet. 
Due to poor sanitation practices and inadequate sewerage 
infrastructure, people infected with O. viverrini and C. 
sinensis pass parasite eggs in their faeces into natural water 
reservoirs, where the parasite eggs are eaten by intermediate 
host snails, for example, aquatic snails of the genus Bithynia, 
the ﬁ  rst intermediate host of O. viverrini. After hatching, free 
swimming parasites, called cercariae, are released from the 
infected snails. Cercariae then locate their next intermediate 
host, cyprinoid ﬁ  shes, encyst in the ﬁ  ns, skin, and muscles of 
the ﬁ  sh, and become metacercariae. The metacercariae are 
infective to humans and other ﬁ  sh-eating mammals upon 
ingestion of raw or undercooked ﬁ  sh in dishes such as koi-pla 
(Figure 1), and in turn the parasite’s life cycle is completed 
(Figure 2).
Most people with opisthorchiasis or clonorchiasis have 
no symptoms. Only 5%–10% of infected people, in general 
those with heavy ﬂ  uke infections, have non-speciﬁ  c symptoms 
such as right upper quadrant abdominal pain, ﬂ  atulence, 
and fatigue [4,5]. Enlargement of the gall bladder can 
be detected by ultrasonography, and is reversed after 
elimination of ﬂ  ukes by praziquantel [6]. Nonetheless, 
heavy, long-standing infection is associated with a number 
of hepatobiliary diseases, including cholangitis, obstructive 
jaundice, hepatomegaly, ﬁ  brosis of the periportal system, 
cholecystitis, and cholelithiasis [7–10]. Moreover, both 
experimental and epidemiologic evidence strongly implicates 
liver ﬂ  uke infection in the aetiology of one of the liver cancer 
subtypes—cholangiocarcinoma (CCA), or cancer of the bile 
ducts [2,11]. 
The pathology of clonorchiasis was recently reviewed 
in detail by Rim [12]. Unlike O. viverrini, C. sinensis is not 
considered a Group I carcinogen (known to be carcinogenic 
in humans) [2], despite its widespread prevalence [13]. In 
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Figure 1. Preparation of a Meal of Koi-Pla Using Uncooked Cyprinoid 
Fishes
(A) Fluke-infected ﬁ  sh are plentiful in the local rivers such as the Chi 
River in Khon Kaen province, Thailand. (B) Local people catch the ﬁ  sh 
in nets and prepare the ﬁ  sh-based meals with local herbs, spices, and 
condiments. (C) The ﬁ  nished dish of koi-pla accompanied by rice and 
vegetables. This dish is a dietary staple of many northeastern Thai 
villagers and is a common source of infection with O. viverrini.
The Neglected Diseases section focuses attention either on a speciﬁ  c disease or 
describes a novel strategy for approaching neglected health issues in general.PLoS Medicine  |  www.plosmedicine.org 1149
this review we therefore focus on opisthorchiasis, where 
the link between ﬂ  uke infection and CCA is more robust 
than for clonorchiasis. Further, the article reviews the 
molecular pathogenesis of opisthorchiasis and associated 
cholangiocarcinogenesis, particularly nitrative and oxidative 
DNA damage and clinical manifestations of CCA that were 
either not addressed or available in our previous review [14].
Liver Fluke Infection and Cholangiocarcinoma
Second to tobacco use, infections are the most important 
preventable source of human malignancies [15–17] (Table 
1). The association between the occurrence of CCA and the 
presence of liver ﬂ  ukes has been known for about 50 years 
[18]. 
In Thailand, the ﬁ  rst evidence for such an association 
came from hospital case series. CCA was observed in a 
high percentage of liver cancers from northeast Thailand, 
where the prevalence of O. viverrini infection is higher than 
elsewhere in this country [19]. More formal correlation 
studies showed that the incidence of CCA in the ﬁ  ve 
major regions of Thailand varied by at least 12-fold and 
had a strong positive correlation with the prevalence of O. 
viverrini infection, as measured by anti-O. viverrini antibody 
titres in the general population (Figure 3) [20,21]. Similar 
correlations have been observed in populations in Laos 
[22,23]. Hepatocellular carcinoma (HCC) shows no such 
relationship. 
Several similar surveys of Thai villagers showed a strong 
association between the intensity of O. viverrini infection, 
parasite-speciﬁ  c antibody response, and abnormalities of the 
biliary tract, including suspected CCA [8,24]. A linear trend 
of the frequency of suspected CCA and O. viverrini faecal egg 
count was observed, where an odds ratio of 14.1 was found 
in a group with elevated egg counts [25]. Moreover, elevated 
anti-O. viverrini antibody titres increase the risk of appearance 
of CCA by up to 27-fold [26]. 
The geographical pattern of liver ﬂ  uke infection in 
Thailand is not uniform, with the greatest prevalence 
doi:10.1371/journal.pmed.0040201.g002
Figure 2. Life Cycles of O. viverrini and C. sinensis
Embryonated eggs are discharged in the biliary ducts and in the stool (1). Eggs are ingested by a suitable snail intermediate host (2); there are more 
than 100 species of snails that can serve as intermediate hosts. Each egg releases a miracidium (2a), which goes through several developmental stages 
(sporocyst [2b], redia [2c], and cercaria [2d]. The cercaria is released from the snail and after a short period of free-swimming time in water, it penetrates 
the ﬂ  esh of a freshwater ﬁ  sh, such as Cyclocheilichthys armatus or Puntius leiacanthus, where it encysts as a metacercaria (3). Humans are infected 
through ingestion of undercooked, salted, pickled, or smoked freshwater ﬁ  shes (4). After ingestion, the metacercaria excysts in the duodenum (5) and 
ascends the biliary tract through the ampulla of Vater. Maturation to adulthood (right, O. viverrini; left, C. sinensis) takes approximately one month (6). 
The adult ﬂ  ukes (measuring 10–25 mm by 3–5 mm) reside in the small and medium-sized biliary ducts. In addition to humans, carnivorous animals can 
serve as reservoir hosts. (Adapted from http://www.dpd.cdc.gov/DPDx/HTML/Opisthorchiasis.htm.)
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occurring in the north (19.3%) and northeast (15.7%), 
compared with the central (3.8%) and southern regions 
(0%) [3]. Khon Kaen province in northeast Thailand has the 
highest incidence of this type of cancer in the world [27,28].
In Thailand, despite widespread implementation of 
chemotherapy with praziquantel in the past, the prevalence 
of O. viverrini in some endemic areas approaches 70%. 
Moreover, in Thailand, liver cancer is the most prevalent 
of the fatal neoplasias, and rates of CCA in regions where 
the parasite is endemic are unprecedented. By way of 
comparison, CCA is responsible for about 19% of liver 
cancers in the United States, compared with 71% in Khon 
Kaen, Thailand, representing the highest incidence of CCA 
in the world in this region [28].
Clinical Manifestations
Most primary malignant liver cancers are of two main 
histologic types distinguished by their cellular origin. HCC 
derives from hepatocytes, the main cells in the liver, and 
is the most common form of liver cancer throughout the 
world. There are several important risk factors that have been 
demonstrated with varied mechanisms of action; 75%–80% 
of cases are attributable to hepatitis B and C infection 
[29,30]. CCA is derived from cholangiocytes, which form 
the epithelial lining of both intrahepatic and extrahepatic 
bile ducts, except for those of the gallbladder. This form 
of liver cancer has a lower operable rate than HCC and 
most cases are currently untreatable except for complete 
liver transplantation [31]. Compared to HCC, CCA is a 
considerably less common form of liver cancer, except in 
regions within East Asia where infection with O. viverrini, and 
to a lesser extent, C. sinensis, is widespread [32].
CCA represents a formidable diagnostic and treatment 
challenge [33]. The wide variation in CCA biology and the 
rarity of the condition (which represents only 3% incidence 
of all gastrointestinal cancers) have signiﬁ  cantly increased 
the difﬁ  culty of any studies involving this cancer, because of 
broad variations in presentation and low study participant 
numbers [34]. The disease’s rarity, combined with its lack of 
early symptoms and a range of possible alternative diagnoses, 
contributes to the challenge of identifying and investigating 
this deadly cancer [35]. Practically all cases are derived from 
glandular tissue, making them adenocarcinomas. Details of 
the gross morphology, histology, mode of spreading, and 
clinical manifestations are outlined in Figure 4 [36,37]. 
[36,37]
Pathogenesis of Liver Fluke-Induced CCA
Mechanical injury and ﬂ  uke metabolic products. Mechanical 
injury from the activities of feeding and migrating ﬂ  ukes 
contributes to biliary damage in the human host. Both 
oral and ventral suckers of the ﬂ  uke hook onto the biliary 
epithelium, resulting in tissue damage even early in 
infection [38]. As the parasite matures, the lesion becomes 
more pronounced and ulcerates. Fluke eggs become 
entrapped in the periductal tissue through the ulcer and 
induce granulomatous inﬂ  ammation around the eggs. The 
granulomata are readily visualized in experimental hamster 
infections and occasionally in human cases with bile duct 
obstruction.
The liver ﬂ  uke secretes or excretes metabolic products, 
some of which are highly immunogenic, from the tegument 
and excretory openings into the bile or culture medium in 
vitro [39,40]. Apart from inducing host immune responses, 
the metabolic products themselves may be toxic to or interact 
with the biliary epithelium [41]. Indeed, mouse ﬁ  broblasts 
co-cultured with O. viverrini adult worms (but physically 
separated in Transwell plates) underwent more than 4-fold 
greater proliferation than cells in media alone [42]. 
Gene microarrays were recently used to explore 
transcriptional changes induced in these murine ﬁ  broblasts 
that were co-cultured with O. viverrini, and the ﬂ  uke 
molecules induced over-expression of several mRNAs 
encoding growth-promoting proteins such as transforming 
growth factor [43]. Moreover, we observed that human CCA 
cell lines underwent excessive proliferation upon stimulation 
with O. viverrini soluble excretory/secretory (ES) products (B. 
Sripa et al., unpublished data). These studies clearly indicate 
that metabolic products of Opisthorchis contain mitogen-like 
activity and can induce cell proliferation. This is in agreement 
with earlier ﬁ  ndings of hyperplasia of biliary epithelial cells in 
opisthorchiasis [38,44]. 
It is intriguing that O. viverrini would secrete a protein that 
promotes cell proliferation and eventually cancer, since the 
Table 1. Malignancies Attributable to Infectious Agents
Pathogen Type Pathogens Malignancies Non-Malignant Diseases Percent of
2002 Cancers
Viruses Human papilloma virus: 13 
carcinogenic strains 
Ano-genital, mouth, pharynx, and cervical cancer Warts, condyloma 5.2
Hepatitis B or C viruses  Hepatocellular carcinoma  Hepatitis, cirrhosis 4.9
Epstein-Barr virus  Nasopharyngeal carcinoma, Burkitt, Hodgkin, and 
immunoblastic lymphoma
Infectious mononucleosis 1.0
Human immunodeﬁ  ciency virus with 
human herpes virus 8 
Kaposi sarcoma, non-Hodgkin lymphoma, and 
other AIDS-associated cancers
AIDS 0.9
Human T cell lymphotrophic virus 
type 1 
Adult T cell leukaemia 0.03
Bacteria H. pylori Gastric carcinoma, MALT lymphoma Gastritis, peptic ulcers 5.5
Helminths Schistosoma haematobium (blood 
ﬂ  uke)
Bladder carcinoma Schistosomiasis 0.1
O. viverrini (liver ﬂ  uke) Cholangiocarcinoma  Opisthorchiasis 0.02
Total 17.8
According to the International Agency for Research on Cancer. Adapted from [15,16].
doi:10.1371/journal.pmed.0040201.t001
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beneﬁ  t to the parasite is unclear. One possibility might be 
that over-production of biliary cells may provide an abundant 
food source for the ﬂ  ukes, which graze on epithelial cells 
and/or their secreted mucins, though it has been proposed 
that C. sinensis ingests host blood through the damaged 
mucosa [12].
Immunopathology. It has long been suspected that 
host immune responses and immunopathologic processes 
mediate hepatobiliary damage in opisthorchiasis [38,45,46]. 
Sripa and Kaewkes [40] showed that inﬂ  ammation around 
infected hamster bile ducts was a consequence of the 
host’s cellular response to Opisthorchis antigens. Marked 
inﬁ  ltration of inﬂ  ammatory cells at the periportal areas of 
infected hamster liver was associated with the presence of 
parasite antigens in the bile duct epithelium as detected by 
immunohistochemistry. Small bile ducts, the ﬁ  rst-order ducts 
(where ﬂ  ukes do not reside because the diameter of the 
ducts is too small), were also positive for O. viverrini antigens 
and were markedly inﬂ  amed. Opisthorchis antigens were also 
observed in macrophages, epithelioid cells, and giant cells of 
the granuloma [40].
Biliary cell damage induced by O. viverrini likely also stems 
from the actions of oxygen radicals such as nitric oxide 
(NO) released from effector cells activated by inﬂ  ammatory 
cytokines [47,48]. These radicals can induce oxidative DNA 
damage to the infected biliary epithelium. Moreover, excess 
NO and other reactive oxygen intermediates produced 
by inﬂ  ammatory cells during infection might exert direct 
cytotoxic and mutagenic effects and cause increased cell 
proliferation [49–51]. Increased formation of 8-nitroguanine 
(8-NO2-G) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-
oxodG) is associated with various pathological conditions 
[52,53], and 8-oxodG is considered to be mutagenic. 
Recently, we reported diffuse nitrative and oxidative DNA 
damage (8-nitroguanine and 8-oxodG) in biliary epithelium 
of hamsters infected with O. viverrini [48], and these DNA 
lesions still remained in the epithelium at least 180 days 
post-infection. Moreover, repeated infections with liver 
ﬂ  uke result in enhanced biliary DNA damage [54]. This may 
be explained by the fact that repeated infection increased 
inducible nitric oxide synthase expression in the bile duct 
epithelium. The DNA damage in infected biliary cells is 
proven to be a result of the inﬂ  ammatory response caused by 
O. viverrini because 8-nitroguanine and 8-oxodG disappeared 
after praziquantel treatment [55]. Usually genotoxic events 
with DNA damage lead to either DNA-mismatch repair 
mechanisms or, if the damage is beyond repair, to cell death 
through apoptosis. NO not only induces DNA damage 
but has been reported to mediate DNA repair inhibition 
[56,57]. Moreover, NO has also been demonstrated to inhibit 
doi:10.1371/journal.pmed.0040201.g003 
Figure 3. Incidence of CCA and O. viverrini in Thailand from 1990–2001
Increasing intensity of red represents increasing prevalence of O. viverrini, while increasing number of dots represents increasing cancer rates. In 
general, higher O. viverrini prevalence correlates with a higher CCA burden, although sporadic anthelmintic therapy has inﬂ  uenced this relationship. It 
should be noted that even one spot represents signiﬁ  cant cancer rates anywhere else in the world. *Truncated age-standardised incidence from 35–64 
years. **Age-standardised incidence of CCA throughout registered regions. Adapted from [20].
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apoptosis downstream of cytochrome c [58]. All of these 
manifestations facilitate carcinogenesis. 
Characterisation of the host immune responses—including 
the cytokine phenotypes—to O. viverrini and their roles in 
immune/inﬂ  ammatory cell-induced tissue damage, as well 
as their relationship with host susceptibility, will likely yield 
a more complete understanding of the immunopathologic 
process involved in liver ﬂ  uke–induced CCA.
Multi-factorial aetiology of CCA. Liver ﬂ  uke–induced CCA 
is therefore generally accepted to be the result of chronic 
inﬂ  ammation [53,58,59]. Several mechanisms by which O. 
viverrini infection may enhance cholangiocarcinogenesis 
have been proposed above, and are summarised in Figure 
5. Indeed, it is almost certain that a combination of those 
pathologies described above (mechanical damage, parasite 
secretions, and immunopathology) culminate in CCA after 
chronic infection with O. viverrini. The primary pathologic 
change, i.e., epithelial desquamation, may be due to 
mechanical irritation caused by the liver ﬂ  uke and/or its 
metabolic products. However, immunopathologic processes 
may contribute to the long-standing hepatobiliary damage. 
During liver ﬂ  uke infection, inﬂ  ammation, periductal ﬁ  brosis, 
and proliferative responses, including epithelial hyperplasia, 
goblet cell metaplasia, and adenomatous hyperplasia, may 
represent predisposing lesions that enhance susceptibility of 
DNA to carcinogens [11,60]. Several N-nitroso compounds 
and their precursors occur at low levels in fermented food 
such as preserved mud ﬁ  sh paste, pla-ra, a condiment that 
is a ubiquitous component of the cuisine of northeastern 
Thailand and Laos. 
Indeed, it has been hypothesised that N-nitroso compounds 
(e.g., nitrosamine) are a primary carcinogen leading to 
CCA in humans in this region [61,62]. We recently reported 
dissimilar gene expression proﬁ  les in CCA tissues from 
patients from sites endemic for O. viverrini in Thailand versus 
non-endemic areas in Japan [63]. Of particular interest was 
the selective up-regulation in Thai patients with CCA of genes 
involved in xenobiotic metabolism, implying that these genes 
may be involved in the detoxiﬁ  cation of possible carcinogens 
such as nitrosamines [63]. CCA can be reliably induced 
in hamsters experimentally infected with O. viverrini and 
exposed to sub-carcinogenic doses of nitrosamine, but not 
in liver ﬂ  uke–infected hamsters not exposed to nitrosamine 
[11].
Apart from exogenous carcinogens, however, endogenous 
nitrosation caused by liver ﬂ  uke infection has also been 
investigated in animals and humans. Experimental 
Opisthorchis infection in hamsters can induce NO synthase 
expression by immune effector cells in inﬂ  amed areas 
surrounding the bile ducts and increased endogenous 
nitrosation of thiazolidine-4-carboxylic acid (thioproline) 
[64]. Several human studies suggest that infected people have 
a higher endogenous nitrosation potential than uninfected 
people [65,66]. Restricted diet studies clearly demonstrated 
an increase in endogenous generation of NO and N-nitroso 
compounds as indicated by increased levels of plasma, 
urinary nitrate and nitrite, and by nitrosation of proline and 
thioproline among infected men compared to members of 
an uninfected control group [25]. Moreover, the difference 
was speciﬁ  cally abolished by praziquantel treatment and by 
co-administration of ascorbic acid with proline. Enhanced 
immune responses to O. viverrini are also associated with an 
increase of endogenous nitrosation in infected individuals 
[67]. Both exogenous and in situ nitrosamine formation may 
lead to DNA alkylation and deamination in predisposed and 
inﬂ  amed tissues [49–51].
Apoptosis is rarely observed in either O. viverrini–infected 
hamster liver or in biliary cells that are co-cultured with 
doi:10.1371/journal.pmed.0040201.g004 
Figure 4. Characteristics of CCA
Morphologically this cancer falls into three subtypes: mass forming, periductal inﬁ  ltrating, and intraductal. This classiﬁ  cation is independent of the 
location of the affected bile duct, which may be intrahepatic (within the liver) or extrahepatic (outside the liver, excluding the gallbladder). The line 
between these subtypes tends to blur as the malignancy matures. Tumour dimensions, mode of spreading, and clinical manifestations are noted. 
Adapted from [36,37] by Giovanni Maki.
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ﬂ  ukes in vitro (B. Sripa et al., unpublished data). This may 
be explained by the mechanisms described above and/or 
the effect of bile acids [58]. Elevation of bile acids has also 
been reported in opisthorchiasis [68]. Bile acids are potent 
tumour promoters and have also been shown to block 
protein degradation of myeloid cell leukemia protein 1 
(MCL-1), a potent anti-apoptotic protein of the BCl-2 family, 
via activation of EGFR signalling [69]. Anti-apoptosis has 
been described in infection-associated cancers such as those 
caused by Helicobacter pylori [70,71]. In the case of O. viverrini 
infection, DNA damage is caused in biliary epithelial cells 
while apoptotic mechanisms are dysregulated, resulting 
in genetic alterations which may become ﬁ  xed, leading to 
malignant transformation.
Implications for Improving Public Health 
From a public health perspective, thorough cooking of the 
ﬁ  sh hosts efﬁ  ciently blocks infection with these parasites. 
In this regard, liver ﬂ  uke–associated CCA is preventable by 
changes in eating habits. Unfortunately, age-old culinary 
preferences for uncooked dishes such as koi-pla (Figure 1) do 
not readily allow for this possibility. Moreover, ﬁ  sh farming 
of grass carp and other susceptible species in ponds that are 
routinely contaminated by untreated sewage has resulted in 
the establishment of infection in ﬁ  sh populations at large, 
which, along with the involvement of animal reservoir hosts, 
makes control of liver ﬂ  uke infection even more challenging 
[13,72]. Nonetheless, given this extraordinary linkage 
between a metazoan parasite and a tumour, characterisation 
of the nature and action of carcinogens of O. viverrini or C. 
sinensis may provide fundamental insights into carcinogenesis 
at large.
In the short term, enhanced knowledge of pathogenesis, 
particularly inﬂ  ammation and its associated DNA damage—
both nitrative and oxidative—may assist in disease control, 
provided the at-risk populations can be educated of the 
doi:10.1371/journal.pmed.0040201.g005 
Figure 5. Proposed Mechanisms of Opisthorchis-Derived CCA Initiation
The three proposed pathways linking the parasite to CCA initiation are mechanical damage (in yellow), molecular products (in blue), and 
immunopathology (in green). Combined, these mechanisms result in several common elements (purple) that all lead to DNA damage. The inhibition 
of a normal DNA damage response is the ﬁ  nal oncogenic factor proposed to dramatically increase the likelihood of a malignant transformation. This 
invariably leads to progression of CCA. (Adapted from [10].) The photographs underneath the schematic show two livers with advanced CCA.
July 2007  |  Volume 4  |  Issue 7  |  e201PLoS Medicine  |  www.plosmedicine.org 1154
elevated risk of CCA from repeated infections. Also, dietary 
changes that include natural products rich in anti-oxidants 
may provide enhanced protection against CCA. In the longer 
term, it should be feasible to develop speciﬁ  c and sensitive 
techniques for detection of oxidative damage markers in 
serum, urine, or faeces for early cancer screening of the at-
risk populations. We and others are now actively engaged in 
this endeavour.  
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